Today: November 28, 2015, 12:20 pm

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress 2014-09-04 16:27:01

Dr. Dallabrida recognized for driving innovation in patient-driven eData technologies that improve clinical research

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress

For PHT Corporation
Brenda Nashawaty, 617-688-3253

PHT Corporation announced that Vice President of Clinical Science and Consulting Services Dr. Susan Dallabrida will present “Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma” at the ESMO 2014 Congress, 26-30 September in Madrid. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.

The ESMO 2014 Congress is sponsored by the European Society for Medical Oncology, the leading European professional organisation representing medical oncologists.

The poster abstract will also be published in the ESMO 2014 Congress Abstract Book, a supplement to the official ESMO journal Annals of Oncology.

The poster was developed by members of the PHT Clinical Science Team, with 100+ years of collective experience in ePROs and COAs:

  • Susan M. Dallabrida PhD, Vice President, Clinical Science & Consulting – Dr. Dallabrida has over 21 years of experience as a senior scientist, consultant and leader in clinical research and development, trial design and strategy, and product development. She has significant regulatory experience for biologics and small molecules.
  • Sarah Tressel Gary PhD, Senior Science Advisor – Dr. Gary has significant experience working with PRO development and validation studies, questionnaire design and working with developers of standardized instruments. She is experienced in migration studies including cognitive debriefing and usability testing in a number of therapeutic areas.

Learn more about the PHT Clinical Science Team:

Learn about the Effective Use, Analysis, and Best [..] in a new educational webinar, 10 September. Register here:

About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 17+ regulatory approvals. Visit for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.

Press Information

Published by
Hossam Abdel-Kader
+43 1 9582319

# 882 Words
Related Articles
More From Business
Photovoltaic marketplace Milk the Sun releases new [..]
BERLIN/MÜNSTER, 26.11.2015 - Milk the Sun, the world"s largest open online marketplace for PV investments has relaunched its [..]
SGS-TÜV Saar Certifies Ethernet/IP from Synopsys According [..]
Munich, 27 November 2015 - SGS-TÜV Saar has certified the hardware function block "DesignWare Ethernet Quality-of-Service (QoS) [..]
New APP allows connection of smartLAB bathroom [..]
Heidelberg-Dossenheim, 26.11.2015 | HMM Group, a midsize company settled in Dossenheim, near Heidelberg, is presenting the fitmefit [..]
Deep Strategy: London Workshop on How to [..]
Every company should have a well-articulated, well-written strategy. But what really is business strategy in the first place? Simply [..]
CONSULEGIS: 25th Anniversary
CONSULEGIS, the international network of quality independent law firms and related professional advisors, celebrates in 2015 [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.